Health, Medical & Pharma News - Updated Daily page 86

AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus

One year of valacyclovir is beneficial for patients with herpes zoster ophthalmicus (HZO), according to a study presented at the annual meeting of the American

AAO: Prior Intravitreal Injections Increase Risk for Cataract Surgery Complications

A history of multiple past intravitreal injections (IVIs) poses a risk for certain future cataract surgery complications, according to a study presented at the

Even at Low Levels, Arsenic in Drinking Water Could Raise Heart Risks

Long-term exposure to even low levels of arsenic in drinking water can raise a person s risk of heart disease, a new study warns.Even folks exposed to arsenic l

Election Stressing You Out? An Expert Has Coping Tips

this can heighten feelings of distress throughout the election. A new poll from the American Psychological Association shows just how distressed Americans are A

Poll Finds Most Americans Stressed Over Election, Future of Nation

76 of Republicans, 71 of Democrats and 74 of Independents.Republicans, Democrats and Independents also shared stress that politicians aren t talking about the t

One Dead, 10 Hospitalized in E. Coli Outbreak Linked to McDonald's Quarter Pounders

An E. coli outbreak tied to McDonald s Quarter Pounders has sickened 49 people in 10 states, killing one and landing 10 more in the hospital.Most of the illness

Abortions Have Increased, Even in States With Bans, Report Finds

A new report shows the number of women getting abortions in the United States has actually increased since the U.S. Supreme Court overturned Roe v. Wade.Since M

Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025

Sangamo Therapeutics, Inc. (Nasdaq SGMO), a genomic medicine company, today announced the outcome of a recent successful interaction with the U.S. FDA, providin

FDA Approves Vyalev for Advanced Parkinson Disease

The U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson disease (PD).Vyalev is the fi

AAO: Wastage Seen With Artificial Expiration of Eye Drops in Ophthalmic Clinics

Artificial expiration dates on eye drops in ophthalmology clinics result in significant waste in terms of medication, plastic, and cost, according to a study pr

Pharmaceutical News and Articles